Gene · 5670
Papers3,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of carcinogenicity following intratesticular transplantation of autologous bone marrow-derived mesenchymal stem cells in non-obstructive azoospermia patients: a retrospective analysis. | Arch Ital Urol Androl | 2025 | 41496688 | PubTator, text mining | PubMed |
| Small extracellular vesicle-associated surface protein biomarkers: emerging roles, opportunities, and challenges in diagnostics. | Front Bioeng Biotechnol | 2025 | 41404198 | PubTator, text mining | PubMed |
| Preoperative selection of best-fit imaging targets and image-guided surgery improves tumor delineation and surgical outcomes: a proof-of-concept study. | Int J Surg | 2025 | 41403269 | PubTator, text mining | PubMed |
| [High YEATS2 expression promotes epithelial-mesenchymal transition in gastric cancer cells by activating the Wnt/β-catenin signaling pathway]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 41311083 | PubTator, text mining | PubMed |
| Serum exosomal miR-1275 as a potential biomarker for the diagnosis and prognostic assessment of hepatocellular carcinoma. | Cancer Biomark | 2025 | 41232091 | PubTator, text mining | PubMed |
| A Circular RNA Promotes Tumor Metastasis through Stabilizing MSI2 Protein in Pancreatic Ductal Adenocarcinoma. | Research (Wash D C) | 2025 | 41049614 | PubTator, text mining | PubMed |
| Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology. | Transl Oncol | 2025 | 40966800 | PubTator, text mining | PubMed |
| SLC16A3 as an immunosuppressive Kupffer cell marker predicts poor prognosis in HBV-positive hepatocellular carcinoma. | J Transl Med | 2025 | 40898206 | PubTator, text mining | PubMed |
| KLB as a potential prognostic biomarker and therapeutic target in colorectal cancer: insights from multi omics and single cell analyses. | Discov Oncol | 2025 | 40879845 | PubTator, text mining | PubMed |
| Elevated expression of transferrin receptor-1 in pancreatic cancer: clinical implications and prognostic significance. | Clin Exp Med | 2025 | 40877641 | PubTator, text mining | PubMed |
| SFRP2 and RPRM as methylation based serum biomarkers for the detection of gastric cancer. | Discov Oncol | 2025 | 40849852 | PubTator, text mining | PubMed |
| Clinical applications of circulating tumor cells in metastasis and therapy. | J Hematol Oncol | 2025 | 40846962 | PubTator, text mining | PubMed |
| Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma. | Discov Oncol | 2025 | 40824331 | PubTator, text mining | PubMed |
| The baseline 18F-FDG PET/CT imaging features in pediatric patients with congenital neuroblastoma. | BMC Med Imaging | 2025 | 40813959 | PubTator, text mining | PubMed |
Postoperative adjuvant hepatic arterial infusion chemotherapy with gemcitabine-cisplatin sequential capecitabine combined with PDL1 inhibitors in resected high-risk intrahepatic cholangiocarcinom: study protocol for a prospective, multicenter, single-arm, phase 2 trial (HgcCP trial). | Front Oncol | 2025 | 40809010 | PubTator, text mining | PubMed |
| Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy. | J Transl Med | 2025 | 40804394 | PubTator, text mining | PubMed |
| Pancreatic adenocarcinoma arising from heterotopic pancreas masquerading as gastritis cystica profunda. | Radiol Case Rep | 2025 | 40746740 | PubTator, text mining | PubMed |
| Furry Animal Allergy: Lipocalins, Serum Albumins, and Secretoglobins-Cross-Reactivity, Diagnosis, and Management Strategies. | Clin Rev Allergy Immunol | 2025 | 40739451 | PubTator, text mining | PubMed |
| The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients. | Sci Rep | 2025 | 40730640 | PubTator, text mining | PubMed |
| Enhancing ELISA Sensitivity: From Surface Engineering to Synthetic Biology. | Biosensors (Basel) | 2025 | 40710084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5670/papers?page=4